Biotech startups that raised a seed round in Massachusetts, United States
Updated 16 Nov 2026
Not sure about the data?
Download a free 10-row sample first. No account, no payment.
| Company | City | Last round | Amount | Date |
|---|---|---|---|---|
| INIA Biosciences | Boston | Seed | $1.5M | 2026-09-08 |
| Portal | Watertown | Seed | $9.0M | 2026-06-18 |
| Gelmedix | Newton | Seed | $13.0M | 2026-02-17 |
| STRM.BIO | Cambridge | Seed | $8.0M | 2026-01-07 |
| Biometry | Boston | Seed | $2.2M | 2025-12-19 |
| NeuroBionics | Cambridge | Seed | $4.2M | 2025-12-10 |
| Kano Therapeutics | Cambridge | Seed | $5.0M | 2025-11-07 |
| Maven Bio | Boston | Seed | $3.1M | 2025-04-16 |
8 rows of the CSV in 5 of its 18 columns.
- The 206 biotech startups in Massachusetts, United States whose last round is a seed round have raised $1.3B in total.
- 38 of them closed their most recent round in the last 12 months, $274.8M combined.
- The largest of those rounds is K2 Therapeutics' $50.0M seed round, dated August 2026.
- The most recent is BridgeHealth Pharmaceuticals' $3.5M seed round on 5 November 2026.
- MassChallenge is an investor in 3 of them, more than any other fund.
- Health care is the most common other sector, with 174 companies (84%).
- 54% were founded in 2020 or later; the median founding year is 2020.
- The most common team size is 1 to 10 employees (63% of companies with a recorded size).
Source: FundingWatcher. Data as of 16 November 2026. "Last 12 months" is the 365 days to that date.
Newest rounds
14 of 206| Company | What they do | Sector | City | Last round | Amount | Date | Total raised | Investors | Employees | Founded |
|---|---|---|---|---|---|---|---|---|---|---|
| INIA Biosciences | INIA Biosciences develops non-invasive, home-administered medical devices to manage chronic inflammatory diseases. | Biotech | Boston | Seed | $1.5M | 2026-09-08 | $1.5M | MassChallenge, MedTech Innovator | 1 to 10 | 2020 |
| Portal | Portal engineers cells to develop new treatments and therapies. | Biotech | Watertown | Seed | $9.0M | 2026-06-18 | $25.7M | Pear VC, Page One Ventures, IA Ventures +2 | 11 to 50 | 2023 |
| Gelmedix | Gelmedix develops a biomaterial platform that improves drug delivery for complex eye treatments. | Biotech | Newton | Seed | $13.0M | 2026-02-17 | $15.4M | Safar Partners, EQx Fund, HTL Innovations | 1 to 10 | 2020 |
| STRM.BIO | STRM.BIO is a biotechnology company that uses extracellular vesicles to deliver gene therapy. | Biotech | Cambridge | Seed | $8.0M | 2026-01-07 | $10.1M | Bill & Melinda Gates Foundation, NYBC Ventures, NCATS | 11 to 50 | 2019 |
| Biometry | Biometry develops diagnostic tools for patients with chronic respiratory conditions. | Artificial intelligence | Boston | Seed | $2.2M | 2025-12-19 | $7.8M | MassChallenge, Elevate Ventures, Sidecar Angels +1 | 11 to 50 | 2013 |
| NeuroBionics | NeuroBionics develops bioelectronic medicine devices that treat disease by modulating nerve activity. | Biotech | Cambridge | Seed | $4.2M | 2025-12-10 | $9.2M | MedTech Innovator, Dolby Family Ventures, GreyMatter +1 | 1 to 10 | 2023 |
| Kano Therapeutics | Kano Therapeutics develops single-stranded DNA for targeted gene correction. | Biotech | Cambridge | Seed | $5.0M | 2025-11-07 | $7.1M | Metaplanet, Taihill Venture, Vsquared Ventures +2 | 1 to 10 | 2021 |
| Alys Pharmaceuticals | Alys Pharmaceuticals develops immuno-dermatology treatments as a biopharmaceutical company. | Biotech | Boston | Seed | $100.0M | 2024-02-12 | $100.0M | Medicxi | 11 to 50 | 2024 |
| Elemind Technologies | Elemind Technologies develops neuromodulation techniques that shape brainwaves and change brain states. | Biotech | Cambridge | Seed | $12.0M | 2024-02-06 | $12.0M | Village Global, E14 Fund, Evolution VC Partners +2 | 11 to 50 | 2019 |
| Pepper Bio | Pepper Bio provides trans-omics research services that help researchers and drug developers discover new drugs. | Biotech | Dedham | Seed | $6.5M | 2023-11-30 | $6.5M | NFX, Silverton Partners, Mana Ventures +2 | 1 to 10 | 2018 |
| JURA Bio | Jura Bio develops therapies that apply CAR-T cell successes to autoimmune disorders. | Biotech | Somerville | Seed | $16.1M | 2023-09-21 | $16.1M | Fontus Capital | 11 to 50 | 2017 |
| Nvelop Therapeutics | Nvelop Therapeutics develops genetic medicines for patients with severe genetic diseases. | Biotech | Cambridge | Seed | $100.0M | 2023-09-20 | $100.0M | F-Prime, Atlas Venture, 5AM Ventures +1 | 51 to 100 | 2022 |
| Hyku | Hyku develops covalent drugs that precisely target disease-causing proteins. | Biotech | Lexington | Seed | $56.0M | 2023-09-19 | $56.0M | KB Investment, RA Capital Management, Novartis Venture Fund +2 | 11 to 50 | 2021 |
| Phenomic AI | Phenomic AI develops a drug discovery platform that discovers therapeutics directly against phenotypic assays. | Artificial intelligence | Waltham | Seed | $6.0M | 2020-10-07 | $11.4M | Creative Destruction Lab, Inovia Capital, Garage Capital +2 | 11 to 50 | 2017 |
Table 1. Biotech startups that raised a seed round in Massachusetts, United States: the 14 newest rounds whose row carries a description, a city, a named fund and an amount. Source: FundingWatcher. Data as of 16 November 2026. Base: 206.
Largest rounds
Last 12 months| # | Company | What they do | Sector | City | Last round | Amount | Date | Total raised | Investors | Employees | Founded |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Gelmedix | Gelmedix develops a biomaterial platform that improves drug delivery for complex eye treatments. | Biotech | Newton | Seed | $13.0M | 2026-02-17 | $15.4M | Safar Partners, EQx Fund, HTL Innovations | 1 to 10 | 2020 |
| 2 | Portal | Portal engineers cells to develop new treatments and therapies. | Biotech | Watertown | Seed | $9.0M | 2026-06-18 | $25.7M | Pear VC, Page One Ventures, IA Ventures +2 | 11 to 50 | 2023 |
| 3 | STRM.BIO | STRM.BIO is a biotechnology company that uses extracellular vesicles to deliver gene therapy. | Biotech | Cambridge | Seed | $8.0M | 2026-01-07 | $10.1M | Bill & Melinda Gates Foundation, NYBC Ventures, NCATS | 11 to 50 | 2019 |
| 4 | NeuroBionics | NeuroBionics develops bioelectronic medicine devices that treat disease by modulating nerve activity. | Biotech | Cambridge | Seed | $4.2M | 2025-12-10 | $9.2M | MedTech Innovator, Dolby Family Ventures, GreyMatter +1 | 1 to 10 | 2023 |
| 5 | Biometry | Biometry develops diagnostic tools for patients with chronic respiratory conditions. | Artificial intelligence | Boston | Seed | $2.2M | 2025-12-19 | $7.8M | MassChallenge, Elevate Ventures, Sidecar Angels +1 | 11 to 50 | 2013 |
| 6 | INIA Biosciences | INIA Biosciences develops non-invasive, home-administered medical devices to manage chronic inflammatory diseases. | Biotech | Boston | Seed | $1.5M | 2026-09-08 | $1.5M | MassChallenge, MedTech Innovator | 1 to 10 | 2020 |
Table 2. Biotech startups that raised a seed round in Massachusetts, United States: the 6 largest rounds of the last 12 months. Source: FundingWatcher. Data as of 16 November 2026.
Most active investors
By companies backed| # | Investor | Type | Location | Companies | Share | Funded, 12 months | Latest |
|---|---|---|---|---|---|---|---|
| 1 | MassChallenge | Startup accelerator | Boston, United States | 3 | 1% | 2 | INIA Biosciences, Biometry |
| 2 | MedTech Innovator | Startup accelerator | Los Angeles, United States | 2 | 1% | 2 | INIA Biosciences, NeuroBionics |
| 3 | Taihill Venture | Venture capital firm | Boston, United States | 2 | 1% | ||
| 4 | RA Capital Management | Startup incubator | Boston, United States | 2 | 1% | ||
| 5 | Half Court Ventures | Venture capital firm | Boston, United States | 2 | 1% | ||
| 6 | Cantos | Micro VC fund | San Francisco, United States | 2 | 1% | ||
| 7 | Undeterred Capital | Venture capital firm | Los Angeles, United States | 1 | 0% | 1 | Portal |
| 8 | Pear VC | Venture capital firm | Menlo Park, United States | 1 | 0% | 1 | Portal |
| 9 | IA Ventures | Venture capital firm | New York, United States | 1 | 0% | 1 | Portal |
| 10 | Page One Ventures | Venture capital firm | San Francisco, United States | 1 | 0% | 1 | Portal |
| 11 | Conscience VC | Venture capital firm | Austin, United States | 1 | 0% | 1 | Portal |
| 12 | HTL Innovations | Startup incubator | Javené, France | 1 | 0% | 1 | Gelmedix |
| 13 | EQx Fund | Angel group | Boston, United States | 1 | 0% | 1 | Gelmedix |
| 14 | Safar Partners | Private equity firm | Cambridge, United States | 1 | 0% | 1 | Gelmedix |
| 15 | NCATS | Government investment office | Bethesda, United States | 1 | 0% | 1 | STRM.BIO |
Table 3. Biotech startups that raised a seed round in Massachusetts, United States: the funds recorded as investors in the most companies. Latest: companies they back that raised in the last 12 months. Source: FundingWatcher. Data as of 16 November 2026.
Sectors
| Sectors | Companies | Share | Total raised |
|---|---|---|---|
| Health care | 174 | 84% | $1.2B |
| Software | 28 | 14% | $160.2M |
| Artificial intelligence | 19 | 9% | $131.8M |
| Hardware | 5 | 2% | $20.6M |
| Fintech | 2 | 1% | $155K |
| Cybersecurity | 1 | 0% |
Table 4. Biotech startups that raised a seed round in Massachusetts, United States by sector. Source: FundingWatcher. Data as of 16 November 2026.
Funding stage
| Funding stage | Companies | Share | Median last round |
|---|---|---|---|
| Seed | 206 | 100% | $2.2M |
Table 5. Biotech startups that raised a seed round in Massachusetts, United States by stage of the most recent round. Source: FundingWatcher. Data as of 16 November 2026.
Cities
Table 6. Biotech startups that raised a seed round in Massachusetts, United States by headquarters city. Source: FundingWatcher. Data as of 16 November 2026.
Rounds by month
| Rounds by month | Companies | Share | Raised |
|---|---|---|---|
| November 2026 | 1 | 3% | $3.5M |
| October 2026 | 2 | 5% | $25.8M |
| September 2026 | 4 | 11% | $22.8M |
| August 2026 | 5 | 13% | $60.5M |
| July 2026 | 1 | 3% | |
| June 2026 | 5 | 13% | $39.3M |
| May 2026 | 1 | 3% | $2.0M |
| April 2026 | 3 | 8% | $19.6M |
| March 2026 | 3 | 8% | $4.5M |
| February 2026 | 2 | 5% | $13.0M |
| January 2026 | 8 | 21% | $69.5M |
| December 2025 | 2 | 5% | $6.4M |
| November 2025 | 1 | 3% | $8.0M |
Table 7. Biotech startups that raised a seed round in Massachusetts, United States: most recent round by month, last 12 months. Source: FundingWatcher. Data as of 16 November 2026.
Most recent round by year
| Most recent round by year | Companies | Share | Raised |
|---|---|---|---|
| 2026 | 35 | 17% | $260.4M |
| 2025 | 35 | 17% | $171.0M |
| 2024 | 21 | 10% | $170.8M |
| 2023 | 16 | 8% | $221.1M |
| 2022 | 15 | 7% | $39.7M |
| 2021 | 16 | 8% | $58.1M |
Table 8. Biotech startups that raised a seed round in Massachusetts, United States by year of the most recent round. Source: FundingWatcher. Data as of 16 November 2026.
Founding year
| Founding year | Companies | Share |
|---|---|---|
| 2023 or later | 50 | 25% |
| 2020 to 2022 | 59 | 29% |
| 2015 to 2019 | 54 | 27% |
| 2010 to 2014 | 25 | 12% |
| Before 2010 | 15 | 7% |
Table 9. Biotech startups that raised a seed round in Massachusetts, United States by founding year. Source: FundingWatcher. Data as of 16 November 2026.
Team size
| Team size | Companies | Share |
|---|---|---|
| 1 to 10 | 124 | 63% |
| 11 to 50 | 63 | 32% |
| 51 to 100 | 4 | 2% |
| 101 to 250 | 2 | 1% |
| 501 to 1,000 | 3 | 2% |
| 1,001 to 5,000 | 1 | 1% |
| 5,001 to 10,000 | 1 | 1% |
Table 10. Biotech startups that raised a seed round in Massachusetts, United States by headcount. Source: FundingWatcher. Data as of 16 November 2026.
Method
- A company is on this list when Biotech is one of its sectors and its most recent funding round is a seed round and its headquarters is in Massachusetts, United States. On 16 November 2026 that is 206 companies.
- Stage, round, amount and date are those of the company's most recent funding round. Amounts are in US dollars as the source records them.
- The table prints the 14 newest rounds whose row is complete: a one-sentence description, a city, a named fund and an amount. The CSV carries all 206 rows: 58 have no round amount, 0 no city and 42 no website. The CSV carries domain, website, LinkedIn and the cached description sentence where present.
Sources, fields and exclusions of both files: Method.
Questions
- How many biotech startups in Massachusetts, United States whose last round is a seed round are on the list?
- 206, in the file dated 16 November 2026. 38 of them closed their most recent round in the last 12 months.
- What does the CSV contain?
- One row per company, 18 columns: name, domain, website, linkedin, description, founded, employees, city, region, country, sectors, funding_stage, last_round, last_round_date, last_round_usd, total_raised_usd, rounds, investors.
- How much does the list cost?
- $29 one-time for all 206 rows, no account. Every investor and every startup, two files, cost $99. With founder contacts, up to 2 founders or CEOs per company compiled to order and mailed within 24 hours, $199.
- What arrives after payment?
- At once: the CSV download link, on the page after payment and by mail.
- Can I see rows before buying?
- The 3 rows under the buy button are rows of the CSV with every column. The form below it mails 10 rows.
- How current is the data?
- The file is dated 16 November 2026. The download link serves the current file each time it is opened.
Not sure about the data?
Download a free 10-row sample first. No account, no payment.